REG - Malin Corp PLC - Notice of Results

MalinAnnouncement

20/08/2018 07:05

RNS Number : 2249Y
Malin Corporation PLC
20 August 2018
 


 
Malin Corporation plc
 
("Malin" or "the Company")
 
Notice of Interim Results
and
Save the Date: Capital Markets Day
 
Dublin-Ireland, 20 August 2018: Malin Corporation plc. (ISE:MLC, "Malin"),  a company investing in high-growth opportunities in the global healthcare sector, today announces that the Company will issue its interim results for the six-month period ended 30 June 2018 on Thursday 6 September 2018.
 
Capital Markets Day
 
Malin also announces today that it will host a Capital Markets Day in London on the afternoon of Thursday 8th November 2018. Further details of the event will follow. 
 
ENDS
 
For further information, please contact:
 
Malin
Adrian Howd, CEO
Tel: +353 (0)19015700
 
Consilium Strategic Communications (Financial PR)
Mary-Jane Elliott / Jonathan Birt
Tel: +44 (0)20 3709 5700
malin@consilium-comms.com
 
Davy Corporate Finance (ESM Adviser)
Brian Garrahy / Daragh O'Reilly
Tel: +353 1 679 6363
 
About Malin Corporation plc
Malin (ISE:MLC) is a company investing in high-growth opportunities in the global healthcare sector. Its purpose is to create shareholder value through the application of long-term capital and operational and strategic expertise to a diverse range of global healthcare businesses. Malin has a focus on innovative businesses underpinned by exceptional science, with a proven, sustainable business model. Formed in 2015, Malin works with its diverse portfolio of investee companies, providing strategic and financial support to enable them to reach their value potential. Malin, with a strong leadership team and Board, is headquartered and domiciled in Ireland and listed on Euronext Dublin, with offices in London and a global investment focus. For more information visit www.malinplc.com.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORUKVRRWOAWAUR